Results 151 to 160 of about 1,626,261 (197)
Some of the next articles are maybe not open access.

Role of Amylin and its Receptors in Neurodegeneration

Current Protein & Peptide Science, 2013
Amylin (islet amyloid polypeptide) and amyloid beta protein (Aβ), identified as proteinaceous deposits within the pancreas of diabetics and the brain of Alzheimer's patients respectively, share many biophysical, physiological and neurotoxic properties.
Wen, Fu, Jack H, Jhamandas
openaire   +2 more sources

Understanding Amylin Receptors

2009
Amylin is a 37 amino acid peptide that is co-secreted with insulin from pancreatic β-cells following nutrient ingestion, acting to inhibit gastric emptying, feeding and insulin-stimulated glycogen synthesis. Amylin is a member of the calcitonin (CT) family of peptides, which include CT, CT gene-related peptides (CGRP) and adrenomedullin (AM).
Just, Rasmus   +4 more
openaire   +2 more sources

Differential antagonism of amylin's metabolic and vascular actions with amylin receptor antagonists

Canadian Journal of Physiology and Pharmacology, 1995
High affinity amylin binding sites are present in the rat nucleus accumbens. These sites bind [125I]amylin with an affinity of 27 pM and have high affinity for salmon calcitonin (sCT) and moderately high affinity for calcitonin gene related peptide (CGRP).
K, Beaumont   +6 more
openaire   +2 more sources

Structural insight into selectivity of amylin and calcitonin receptor agonists

Nature Chemical Biology, 2023
Amylin receptors (AMYRs), heterodimers of the calcitonin receptor (CTR) and one of three receptor activity-modifying proteins, are promising obesity targets. A hallmark of AMYR activation by Amy is the formation of a 'bypass' secondary structural motif (residues S19-P25).
Jianjun Cao   +14 more
openaire   +2 more sources

Amylin Receptor: A Potential Therapeutic Target for Alzheimer’s Disease

Trends in Molecular Medicine, 2017
Alzheimer'sdisease (AD) is a progressive neurodegenerative disorder, characterized by senile plaques constituting extracellular deposits of β-amyloid (Aβ) fibrils. Since Aβ accumulation in the brain is considered an early event preceding, by decades, cognitive dysfunction, disease-modifying treatments are aimed at facilitating clearance of this protein
Ryoichi Kimura   +2 more
exaly   +3 more sources

Oral delivery of the amylin receptor agonist pramlintide

Peptide Science, 2023
Abstract Amylin receptor agonism safely benefit diabetic patients, reducing the insulin requirements and glycemic excursions. Pramlintide is the triple proline human amylin analogue first used as injectable drug, but lacking physico‐chemical compatibility when co‐formulated with insulin. Here, we report the design and characterization
Celimar Sinézia   +3 more
openaire   +1 more source

Amylin is an agonist of the renal porcine calcitonin receptor.

Endocrinology, 1994
The cloned renal porcine calcitonin (pCT) receptor cDNA expressed by transient transfection in COS-1 cells or stable transfection in HEK-293 cells was assayed for interaction with CT, amylin, and CT gene-related peptide. Both [125I]salmon CT ([125I]sCT) and [125I]rat amylin displayed specific binding to transfected cells, and in both cases, pCT and rat
P M, Sexton   +4 more
openaire   +2 more sources

Pharmacology of receptors for calcitonin gene-related peptide and amylin

Trends in Pharmacological Sciences, 1995
Calcitonin gene-related peptide (CGRP), a widespread neuropeptide with multiple actions, has substantial homology with amylin, a peptide implicated in insulin-resistant diabetes, and adrenomedullin, a recently discovered potent vasodilator. There is controversy over the existence of CGRP receptor subtypes, and whether independent receptors exist for ...
openaire   +2 more sources

Amylin and amylin receptors in Alzheimer's disease

2020
Wen Fu, Jack H. Jhamandas
openaire   +1 more source

Home - About - Disclaimer - Privacy